TYK-00540 for adults with solid tumors
Treatments studied
Part of Cancer clinical trials.
This trial tests a new drug, TYK-00540, for people with solid tumors that have not responded to or cannot tolerate standard treatments. It also looks at specific types of breast and ovarian cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a solid tumor that has spread or cannot be removed and standard treatments have stopped working or caused too many side effects.
- You are able to perform daily activities with little or no help (ECOG 0 or 1).
- Your major organs (like liver, kidneys, heart, and blood cells) are working well enough.
- You are willing to use effective birth control during and for 6 months after treatment.
- You have not had certain cancer treatments within the last 2 to 4 weeks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new tablet, TYK-00540, alone or with another drug, for people with advanced solid tumors that have stopped responding to standard treatments. It aims to see if the drug can shrink tumors or slow their growth.
This trial tests an experimental drug called TYK-01054 for people with advanced solid tumors that have stopped responding to standard treatment. The drug targets a specific cell pathway (Hippo) that may help slow or stop tumor growth.
This trial is testing a new drug called KY-0301 for people with advanced solid tumors that haven't responded to other treatments. It aims to see if the drug is safe and effective, and it will be given in two parts to find the right dose and for specific cancer types.
This study tests a new drug called TUB-040 for people with ovarian cancer that has stopped responding to platinum chemotherapy, or with a type of lung cancer that has returned or spread. The drug is designed to target cancer cells and deliver a powerful anti-cancer agent directly to them, potentially slowing the disease.
This trial tests a new drug, SYHA1813, given alone or with other treatments, for people with advanced solid tumors that cannot be removed by surgery or have spread. The goal is to see if it is safe and effective.
This study tests an investigational drug, GSK5533524, either alone or with other treatments, in adults with advanced solid tumors that have stopped responding to standard therapies. The goal is to find a safe dose and see if it helps shrink or control the tumor.
Hear when a new Locally Advanced or Metastatic Solid Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.